Arkolith/Insider Trading/TYRA/Form 4

Bensen Daniel

Chief Discovery OfficerTyra Biosciences, Inc. (TYRA) · full profile →Form 4 · filed Dec 16, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$181K
Net Open-Market Flow
-$181K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 12, 2025Sell(S)8K$22.64$181K163K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-320941) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML